Asa Biopharm's Podcast
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 73:43:33
- Mais informações
Informações:
Sinopse
In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.
Episódios
-
Episode 48: PhUSE, the Pharmaceutical Users Software Exchange
02/12/2017 Duração: 51minStephen Bamford, Chris Hurley and James Johnson discuss the motivation for and initiatives of PhUSE
-
Episode 47: Pediatric Medical Product Development
06/11/2017 Duração: 45minSusan Wang and Amy Xia discuss the challenges of pediatric medical product development.
-
Episode 46: Re-Randomization of Subjects Scientific Working Group
15/10/2017 Duração: 53minGheorghe Doros, Anastasia Ivanova, and George Papakostas discuss the Sequential Parallel Comparison Design and the newly-formed Clinical Trial Designs with Re-Randomization of Subjects Scientific Working Group.
-
Episode 45: Kelly Zou
19/09/2017 Duração: 24minKelly shares her thoughts on real world data and real world evidence in the healthcare and pharmaceutical industry.
-
Episode 44: Weili He and Martin Ho
17/08/2017 Duração: 35minWeili and Martin discuss the 2017 Regulatory-Industry Statistics Workshop.
-
Episode 43: 40th Anniversary of PSI
27/07/2017 Duração: 47minAndy Grieve, Nigel Howitt, John Lewis and Lucy Rowell reminisce about PSI’s past and look forward to its future.
-
Episode 42: Committee on Minorities in Statistics
29/06/2017 Duração: 47minReneé Moore and Janelle Charles discuss the mission and major initiatives of the Committee on Minorities in Statistics and the many ways statisticians can get involved.
-
Episode 41: Liz Stuart
05/06/2017 Duração: 42minLiz discusses the Health Policy Statistics Section (HPSS) of the ASA, the upcoming 2018 International Conference on Health Policy Statistics (ICHPS), as well as some of the major topic areas of focus for health policy statistics.
-
Episode 40: Estimands
08/05/2017 Duração: 56minYuki Ando, Frank Bretz, Rob Hemmings and Tom Permutt discuss estimands and the ICH E9 revisions.
-
Episode 39: Alex Dmitrienko
14/03/2017 Duração: 58minAlex discusses multiplicity, the FDA’s draft guidance on multiple endpoints, and the BIOP pilot online training program.
-
Episode 38: Amanda Golbeck
20/02/2017 Duração: 33minAmanda discusses statistical leadership and her book Leadership and Women in Statistics.
-
Episode 37: Multiregional Clinical Trials
26/01/2017 Duração: 01h01minAloka Chakravarty, Laurie Letvak and Bill Wang discuss MRCTs and the draft ICH E17 guidance.
-
Episode 36: Statistical Leadership
21/12/2016 Duração: 59minSonia Davis, Bill Sollecito and Paula Brown Stafford discuss statistical leadership and leadership training at the University of North Carolina at Chapel Hill.
-
Episode 35: EFSPI Benefit-Risk Working Group
10/11/2016 Duração: 44minAlexander Schacht and Ian Hirsch discuss benefit-risk and the efforts of the EFSPI working group.
-
Episode 34: Patient Preferences in Medical Product Evaluation
07/10/2016 Duração: 45minTelba Irony and Martin Ho discuss the important of patient preferences.
-
Episode 33: Freda Cooner and Ed Luo
06/09/2016 Duração: 19minFreda and Ed discuss what to expect at the 2016 Biopharm Workshop
-
Episode 32: Marisa Bacchi
17/08/2016 Duração: 40minMarisa Bacchi discusses the first EFSPI workshop on regulatory statistics.
-
Episode 31: Data Science
14/07/2016 Duração: 47minMarie Davidian, Montse Fuentes & Mladen Vouk define data science, discuss related ASA initiatives and describe the data science program at NC State.
-
Episode 30: Women in Statistics and Data Science Conference
25/05/2016 Duração: 33minDonna LaLonde, Dalene Stangl & Jiayang Sun discuss the origins and program for the upcoming WSDS conference.
-
Episode 29: Statistics and Pharmacometrics Interest Group
30/04/2016 Duração: 34minAlan Hartford and Matt Rotelli discuss the mission of the group and the importance of communication between statisticians and pharmacometricians.